期刊文献+

二次检索

题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息
共找到271篇文章
< 1 2 14 >
每页显示 20 50 100
Angiotensin-converting Enzyme Gene Insertion/Deletion Polymorphism in Children with Henoch-Schonlein Purpua Nephritis 被引量:17
1
作者 周建华 田雪飞 徐钦儒 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2004年第2期158-161,共4页
This study investigated the relationship between angiotensin-converting enzyme (ACE) gene insertion/deletion polymorphism and the occurrence, severity, prognosis of HSPN. The polymorphism of ACE gene in 103 HSPN case... This study investigated the relationship between angiotensin-converting enzyme (ACE) gene insertion/deletion polymorphism and the occurrence, severity, prognosis of HSPN. The polymorphism of ACE gene in 103 HSPN cases and 100 healthy children was studied by using the polymerase chain reactions (PCR). Its relation to the clinical manifestation, pathological classification and prognosis of HSPN was analyzed accordingly. The results showed that: (1) there was a significantly higher frequency for DD genotype in HSPN children (P<0.01); (2) DD genotype was more frequently seen in HSPN children with gross hematuria and massive proteinuria (P<0.05), while DI genotype was more common in HSPN children group with renal insufficiency (P<0.05); (3) although mesangial proliferative lesion was most frequently observed in 21 biopsied HSPN children, and DD genotype frequency was still higher in children with severe pathology (Class Ⅲ Ⅳ); (4)II genotype was significantly frequent in HSPN children with complete remission in the follow-up of 32 HSPN children. It was concluded that the deletion allele of ACE gene might play a role, at least to some extent, in the occurrence, deterioration and progression in juvenile HSPN. 展开更多
关键词 angiotensin-converting enzyme gene insertion/deletion polymorphism henoch-schonlein purura nephritis children
下载PDF
Current views of the relationship between Helicobacter pylori and Henoch-Schonlein purpura in children 被引量:31
2
作者 Li-Jing Xiong Meng Mao 《World Journal of Clinical Pediatrics》 2016年第1期82-88,共7页
Helicobacter pylori(H. pylori) is one of the factors involved in the pathogenesis of various gastrointestinal diseases and may play a potential role in certain extraintestinal diseases. H. pylori infection are mainly ... Helicobacter pylori(H. pylori) is one of the factors involved in the pathogenesis of various gastrointestinal diseases and may play a potential role in certain extraintestinal diseases. H. pylori infection are mainly acquired during childhood, and it has been reported that in endemic areas of China the infection rates are extraordinarily higher in HSP children, particular those with abdominal manifestations. Furthermore, eradication therapy may ameliorate Henoch-Schonlein purpura(HSP) manifestations and decrease the recurrence of HSP. Therefore, results suggested that detection of H. pylori infection by appropriate method ought to be applied in HSP children. Current evidences indicate that local injury of gastric mucosa and immunological events induced by H. pylori infection are involved in the development of HSP. Increased serum Ig A, cryoglobulins, C3 levels, autoimmunity, proinflammatory substances and molecular mimicry inducing immune complex and cross-reactive antibodies caused by H. pylori infection might play their roles in the course of HSP. However, there are no investigations confirming the causality between H. pylori infection and HSP, and the pathogenesis mechanism is still unclear. More bench and clinical studies need to be executed to elaborate the complex association between H. pylori and HSP. 展开更多
关键词 HELICOBACTER PYLORI henoch-schonlein purpura children
下载PDF
Childhood Henoch-Schnlein Purpura Nephritis and IgA Nephropathy: One Disease Entity?——A Clinico-pathologically Comparative Study 被引量:2
3
作者 周建华 黄爱霞 +1 位作者 刘铜林 匡裕玖 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2005年第5期538-542,551,共6页
Summary: In order to characterize their relationship through clinicopathological comparison between IgA nephropathy and Henoch-Schoenlein purpura nephritis (HSPN), 31 children with IgA nephrop- athy aged between 3 ... Summary: In order to characterize their relationship through clinicopathological comparison between IgA nephropathy and Henoch-Schoenlein purpura nephritis (HSPN), 31 children with IgA nephrop- athy aged between 3 to 15 years and 120 children with HSPN aged between 4 to 15 years were compared with each other in clinical manifestation, blood biochemistry, serum immunology and followup study. Renal pathological findings under light microscope, immunofluorescence and electronic microscope were analyzed and also compared between 31 children with IgA nephropathy and 32 biopsied children with HSPN. The results showed that the onset age was over 12 years in 25.8 % children with IgA nephropathy, but only 10 % in HSPN (P〈0.05). The clinical patterns of IgA nephropathy and HSPN were similar, but extra-renal manifestations were more often in HSPN, all of them had skin purpura, 59 % had gastrointestinal symptoms and 47 % suffered from arthralgia, compared with only abdominal pain in 3.2 % children with IgA nephropathy. The renal pathological investigation showed global sclerosis in 35.5 % of IgA nephropathy and 3.1% of HSPN, mesangial sclerosis in 41.9 % of IgA nephropathy and 6.3 % of HSPN, but endothelial proliferation in 65.6 % of HSPN and 29 % of IgA nephropathy (all P〈0.01). Thin basement membrane nephropathy was only found in 6. 5 % children with IgA nephropathy, no in HSPN. The electronic dense deposits in HSPN were sparse, lodse and wildly spread in glomerular mesangium, subendothelial area and even intra basement membrane, but it was dense, lumpy and mostly limited in mesangium and paramesangium in IgA nephropathy. Predominant IgA deposits were found in 81.2% of HSPN, and overwhelming IgG deposits in 12.5 % of HSPN with relatively weak IgA deposits, moreover 6.3 % of HSPN showed linear IgG deposits in glomerular capillary. Totally 71. 9 G of HSPN had IgG deposits in glomeruli and only 19.4% of IgA nephropathy showed glomerular IgG deposits (P〈0. 01). No IgG deposit was observed in 81. 6 % of IgA nephropathy, among them most showed IgA and IgM and/or C3 deposits, moreover overwhelming IgG deposits and linear IgG deposits couldn't be found in IgA nephropathy. Mean 20 months follow-up showed complete remission in 72.5% of HSPN, but only 19.4% in IgA nephropathy after 34 months follow-up. Moreover, 64.5 % of IgA nephropathy had consistent hematuria and proteinuria and 16. 1% had active nephritides (P〈0.05). It was concluded that significant clinico-pathological difference was found between HSPN and IgA nephropathy, which didn't support the one disease entity hypothesis. HSPN and IgA nephropathy are probably two diseases with similar immune abnormalities. 展开更多
关键词 children IgA nephropathy henoch-schonlein purpura nephritis IMMUNOPATHOLOGY clinico-pathological evaluation
下载PDF
Spectrum of Henoch-Schonlein Purpura in Children: A Single-Center Experience from Western Provence of Saudi Arabia 被引量:1
4
作者 Esraa M. Bukhari Khouloud A. Al-Sofyani Mohammed Ahmed Muzaffer 《Open Journal of Rheumatology and Autoimmune Diseases》 2015年第1期17-22,共6页
The aim of this study was to describe the common presentation, frequency, and complications of Henoch-Schonlein purpura (HSP) in patients <18 years who were followed up at King Abdulaziz University Hospital, Jeddah... The aim of this study was to describe the common presentation, frequency, and complications of Henoch-Schonlein purpura (HSP) in patients <18 years who were followed up at King Abdulaziz University Hospital, Jeddah over the last 12 years. We performed a retrospective chart review of the medical records of all patients diagnosed as HSP. During this period, only 29 cases were reported (15 males, 14 females), with the mean age at the diagnosis 7.5 years. 82% percent of the patients had joint involvement in the form of arthritis or arthralgia;17.2% had no joint involvement. Abdominal manifestations were reported in 72.4% of the patients, while renal involvement was documented in 24.1% of the cases;two patients had scrotal involvement. Four patients (13.7%) had a recurrence within four months of HSP diagnosis. However, all patients had full recovery within a month. More research is warranted to study the prevalence, clinical manifestations, preceding factors, and complications of HSP in a Saudi-based cohort. 展开更多
关键词 children Diagnosis henoch-schonlein purpura PEDIATRICS Presentation RENAL Involvement
下载PDF
Controlled study on therapeutic effect of vessel pricking therapy and western medication for treatment of henoch-schonlein purpura nephritis 被引量:1
5
作者 杨洪娟 庄克生 +1 位作者 卜彤文 穆立芹 《World Journal of Acupuncture-Moxibustion》 2010年第3期1-5,18,共6页
Objective To compare the difference of therapeutic effects between vessel pricking therapy and Prednisone for treatment of henoch-schonlein purpura nephritis(HSPN).Methods Seventy cases of acute purpura nephritis sy... Objective To compare the difference of therapeutic effects between vessel pricking therapy and Prednisone for treatment of henoch-schonlein purpura nephritis(HSPN).Methods Seventy cases of acute purpura nephritis syndrome were randomly divided into an observation group (40 cases) and a control group (30 cases).Patients in observation group were differentiated into sthenic and asthenic syndromes.Vessel pricking therapy was applied at Hégǔ(合谷 LI 4),Qūchí(曲池 LI 11),Xuèhǎi(血海 SP 10) etc.by three-edged needle for sthenic symptom;shallow needling was used at Píshū(脾俞 BL 20),Shènshū(肾俞 BL 23),Zúsānlǐ(足三里 ST 36) etc.by filiform needle for asthenic syndromes.The control group was treated with oral administration of Prednisone.The symptom score of TCM,24 h urinary protein,red blood cell count of urinary sediment of both groups were observed before and after treatment and therapeutic effects were compared.Results The total effective rate of 92.5%(37/40) in observation group was superior to that of 80.0%(24/30) in control group,and there was a significant difference between two groups (P0.05);the symptom score of TCM,24 h urinary protein,red blood cell count of urinary sediment were all improved in both groups after treatment (all P0.05),and moreover,the improvement in observation group was superior to that of control group (all P0.05);after treatment,the symptom score of TCM of sthenic syndrome was lower than that of asthenic syndrome in observation group (P0.05).Conclusion Vessel pricking therapy has a significant therapeutic effect for treatment of HSPN,superior to that of oral administration of Prednisone,and the therapeutic effect is better for treating sthenic syndrome than for asthenic syndrome. 展开更多
关键词 henoch-schonlein purpura nephritis Vessel Pricking Therapy Randomized Controlled Trials (RCT)
原文传递
Role of p300 in the pathogenesis of Henoch-Schonlein purpura nephritis and as a new target of glucocorticoid therapy in mice 被引量:13
6
作者 Ming-Yu Jiang Wei Li +2 位作者 Xiang-Ping Xu Jie-Qing Zhou Hong Jiang 《Chinese Medical Journal》 SCIE CAS CSCD 2019年第16期1942-1950,共9页
Background: Henoch-Schonlein purpura nephritis (HSPN) is a very common secondary kidney disease of childhood. Its pathogenesis and the treatment mechanism of glucocorticoid have not been fully elucidated. The aim of t... Background: Henoch-Schonlein purpura nephritis (HSPN) is a very common secondary kidney disease of childhood. Its pathogenesis and the treatment mechanism of glucocorticoid have not been fully elucidated. The aim of this study was to determine the relationship between p300 and the pathogenesis, glucocorticoid therapy in mice with HSPN, respectively. Methods: Forty-eight C57BL/6N male mice, weighing 18 to 20 g, were selected (3–4 weeks old, n = 8 per group). The mice in the normal control group (Group I) were given normal solvent and the HSPN model group (Group II) were given sensitizing drugs. The mice in Group III were injected intraperitoneally with dexamethasone after being given sensitizing drugs. Meanwhile, mice in Groups IV, V and VI with conditional knockout of p300 were also given normal solvent, sensitizing drugs and dexamethasone. The levels of serum IgA, creatinine, and circulating immune complex (CIC) concentrations, 24 h urinary protein and urinary erythrocyte in C57 wild mice, and p300 conditional knockout mice in each group were measured. The expression of p300 in renal tissues and the expression of glucocorticoid receptor (GR)α and β, transforming growth factor (TGF)-β1, and activator protein (AP)-1 after dexamethasone treatment were determined by real-time polymerase chain reaction and Western blotting. Results: Compared with the normal solvent control group (Group I), the expression of p300 mRNA in the model group (Group II) was significantly up-regulated. Western blotting further confirmed the result. Urinary erythrocyte count, 24 h urinary protein quantification, serum IgA, CIC, and renal pathologic score in Group V were distinctly decreased compared with non-knockout mice in Group II (9.7 ± 3.8 per high-power field [/HP] vs. 18.7 ± 6.2/HP, t = 1.828, P = 0.043;0.18 ± 0.06 g/24 h vs. 0.36 ± 0.08 g/24 h, t = 1.837, P = 0.042;18.78 ± 0.85 mg/mL vs. 38.46 ± 0.46 mg/mL, t = 1.925, P = 0.038;0.80 ± 0.27 μg/mL vs. 1.64 ± 0.47 μg/mL, t = 1.892, P = 0.041;7.0 ± 0.5 vs. 18.0 ± 0.5, t = 1.908, P = 0.039). Compared with non-knockout mice (Group III), the level of urinary erythrocyte count and serum IgA in knockout mice (Group VI) increased significantly after treatment with dexamethasone (3.7 ± 0.6/HP vs. 9.2 ± 3.5/HP, t = 2.186, P = 0.024;12.38 ± 0.26 mg/mL vs. 27.85 ± 0.65 mg/mL, t = 1.852, P = 0.041). The expression level of GRα was considerably increased in the knockout group after dexamethasone treatment compared with non-knockout mice in mRNA and protein level (t = 2.085, P = 0.026;t = 1.928, P = 0.035), but there was no statistically significant difference in the expression level of GRβ between condition knockout and non-knockout mice (t = 0.059, P = 0.087;t = 0.038, P = 1.12). Furthermore, the expression levels of glucocorticoid resistance genes (AP-1 and TGF-β1) were notably increased after p300 knockout compared with non-knockout mice in mRNA and protein level (TGF-β1: t = 1.945, P = 0.034;t = 1.902, P = 0.039;AP-1: t = 1.914, P = 0.038;t = 1.802, P = 0.041). Conclusions: p300 plays a crucial role in the pathogenesis of HSPN. p300 can down-regulate the expression of resistance genes (AP-1 and TGF-β1) by binding with GRα to prevent further renal injury and glucocorticoid resistance. Therefore, p300 is a promising new target in glucocorticoid therapy in HSPN. 展开更多
关键词 P300 henoch-schonlein purpura nephritis PATHOGENESIS GLUCOCORTICOID treatment
原文传递
紫癜1号方治疗儿童过敏性紫癜性肾炎临床观察
7
作者 朱卫娜 曾慕煌 +5 位作者 喻闽凤 朱玲 黄烁佳 林雁 陈立红 余红英 《江西中医药大学学报》 2024年第1期54-57,共4页
目的:观察紫癜1号方对紫癜性肾炎(HSPN)患儿外周血嗜酸性粒细胞及其凋亡因子Fas蛋白表达的影响。方法:选取2019年10月1日—2020年12月30日于深圳市中医院门诊和住院部诊治的HSPN患儿60例,随机分为观察组和对照组,各30例。观察组予紫癜1... 目的:观察紫癜1号方对紫癜性肾炎(HSPN)患儿外周血嗜酸性粒细胞及其凋亡因子Fas蛋白表达的影响。方法:选取2019年10月1日—2020年12月30日于深圳市中医院门诊和住院部诊治的HSPN患儿60例,随机分为观察组和对照组,各30例。观察组予紫癜1号方加减及中药针剂治疗,对照组给予西医常规治疗,2组疗程均为12周。观察治疗前、治疗第0、4、8、12周各时间段的尿N-乙酰氨基葡萄糖苷酶(NAG)、尿微量白蛋白(mALB)、β2-微球蛋白(β2-MG),以及血嗜酸性粒细胞(EOS)、死亡诱导因子(Fas)等变化情况和疗效变化。结果:治疗第4、8周时,观察组总有效率分别为83.33%、96.67%,明显高于对照组,组间比较有显著性差异(P<0.05);第4、8周时,观察组降低患儿NAG的效果显著优于对照组(P<0.01);各个观察时点观察组降低β2-MG的效果均优于对照组(P<0.05);第4、12周时,观察组降低m ALB的效果优于对照组(P<0.05)。治疗第4周时,促进Fas抗原表达、降低EOS的效果对照组优于观察组,差异有统计学意义(P<0.01)。结论:紫癜1号方在早期能改善HSPN患儿临床症状,对改善早期肾损害指标起效更快,作用更持久。 展开更多
关键词 紫癜性肾炎 紫癜1号方 儿童 中药针剂
下载PDF
凉山彝族地区儿童紫癜性肾炎临床病理特点及预后分析
8
作者 李群 石艳 +3 位作者 花媛媛 黄兴琼 周继敏 张月 《西部医学》 2024年第6期895-898,905,共5页
目的探讨凉山彝族地区儿童紫癜性肾的临床病理特点及预后。方法收集2014年1月—2019年12月我院诊断为紫癜性肾炎的患儿383例的临床资料,完善肾组织活检的患儿52例,将临床、病理资料进行回顾性分析,总结凉山彝族地区儿童紫癜性肾炎的年... 目的探讨凉山彝族地区儿童紫癜性肾的临床病理特点及预后。方法收集2014年1月—2019年12月我院诊断为紫癜性肾炎的患儿383例的临床资料,完善肾组织活检的患儿52例,将临床、病理资料进行回顾性分析,总结凉山彝族地区儿童紫癜性肾炎的年龄、性别、民族分布情况、临床病理特点及预后。结果383例紫癜性肾炎患儿中彝族发病高于汉族(彝∶汉=1.87∶1),彝族女性儿童发病高于彝族男性儿童(彝族女∶彝族男=1.25∶1),汉族女性儿童发病低于汉族男性儿童(汉族女∶汉族男=0.87∶1)。从发病到尿检异常时间看,70.3%肾损害发生在1月内,临床分型主要以血尿和蛋白尿型为主,等级间差异有统计学意义(Z=1.982,P=0.042),其次是肾病综合征型,病理分级以Ⅱ、Ⅲ级为主,占88.4%,在病理分级Ⅱ、Ⅲa级中也以血尿和蛋白尿型为主,病理Ⅲb级以上以肾病综合征型为主,临床分型与病理分级关系各组之间比较差异有统计学意义(均P<0.05),但尤以肾病综合征型差异有显著意义(Z=2.626,P<0.001);尿蛋白定量越高(P<0.05),病理分级越高。汉族和彝族在不同病理分级的比较差异有统计学意义(Z=2.044,P=0.041),彝族儿童肾脏损害程度显得更重;而不同性别在病理分级的比较差异无统计学意义(P≥0.05)。激素、免疫抑制剂、ACEI等治疗效果良好。结论凉山地区儿童紫癜性肾炎以彝族女性儿童发病率更高。同时病理分级与尿蛋白定量呈正相关,且病理分级越高,临床分型以肾病型为主,但也存在病理分级与尿蛋白定量、临床分型不一致表现,提示早期肾活检的重要性;激素和免疫抑制剂治疗效果肯定,预后大多良好。 展开更多
关键词 彝族儿童 紫癜性肾炎 病理特点 预后
下载PDF
过敏性紫癫患儿外周血单个核细胞中ASC mRNA和NLRP3 mRNA表达水平及其与并发肾炎的关系
9
作者 付中英 杨燕玲 +4 位作者 苏月华 于晗澍 李曼 朱凤芹 常红 《中国妇幼健康研究》 2024年第11期20-31,共12页
目的探讨过敏性紫癫(HSP)患儿外周血单个核细胞中炎性体凋亡相关斑点样蛋白(ASC)mRNA和核苷酸结合寡聚化结构域样受体蛋白3(NLRP3)mRNA表达水平及其与并发肾炎的关系。方法选择2020年7月至2022年12月于菏泽市立医院就诊的76例HSP患儿为... 目的探讨过敏性紫癫(HSP)患儿外周血单个核细胞中炎性体凋亡相关斑点样蛋白(ASC)mRNA和核苷酸结合寡聚化结构域样受体蛋白3(NLRP3)mRNA表达水平及其与并发肾炎的关系。方法选择2020年7月至2022年12月于菏泽市立医院就诊的76例HSP患儿为观察组,收集其临床资料;以同期在院体检的48例健康儿童为对照组。根据患儿是否并发肾炎,将观察组分为过敏性紫癜肾炎(HSPN)组22例与HSP组54例。比较观察组与对照组、HSPN组和HSP组及对照组的临床资料,采用Logistic回归模型分析HSP患儿并发肾炎的危险因素,采用限制性立方样条模型分析ASC mRNA和NLRP3 mRNA与HSP患儿并发肾炎的关系。利用y=1-1/(1+e-z)回归方程建立HSP患儿并发肾炎的预测模型,以十字交叉验证法验证模型的稳定性。结果观察组与对照组的体质量指数(BMI)、白细胞(WBC)、血小板(PLT)、红细胞(RBC)、中性粒细胞(NEU)、C反应蛋白(CRP)、甘油三酯(TG)、血清肌酐(Scr)、尿素氮(BUN)、尿微量白蛋白(mALB)、纤维蛋白原(FIB)、纤维蛋白原降解产物(FDP)、D-二聚体(D-D)、低密度脂蛋白胆固醇(LDL-C)、免疫球蛋白(Ig)A、IgG、IgM、白细胞介素(IL)-16、IL-18、胰岛素样生长因子-1(IGF-1)、胰岛素样生长因子结合蛋白-3(IGFBP-3)、胱抑素(CysC)、肿瘤标志物(TM)、血管性血友病因子(vWF)、血管细胞间黏附分子-Ⅰ(sVCAM-Ⅰ)、结缔组织生长因子(CTGF)、基质金属蛋白酶9(MMP9)、ASC mRNA、NLRP3 mRNA比较,差异均有统计学意义(t=2.587~22.473,P<0.05)。调整相关混杂因素后,按照总HSP切点将ASC mRNA转化为二分类变量后,与低ASC mRNA表达水平比较,高ASC mRNA表达水平与HSP有关联(OR=0.723,95%CI:0.672~0.831,P<0.001);按照总HSP切点将NLRP3 mRNA转化为二分类变量后,与低NLRP3 mRNA表达水平比较,高NLRP3 mRNA表达水平与HSP有关联(OR=0.642,95%CI:0.611~0.791,P<0.001)。HSPN组、HSP组和对照组的BMI、WBC、PLT、RBC、NEU、CRP、TG、Scr、BUN、mALB、FIB、FDP、D-D、IgA、IgG、IgM、IL-16、IL-18、IGF-1、IGFBP-3、CysC、TM、vWF、sVCAM-Ⅰ、CTGF、MMP9、ASC mRNA、NLRP3 mRNA比较,差异均有统计学意义(t=2.461~27.327,P<0.05)。多因素Logistic回归模型分析显示,Scr≥92.16μmol/L、BUN≥7.74mmol/L、mALB≥0.58mg/L、D-D≥1.12mg/L、IgA≥2.54g/L、IGF-1≥0.77ng/L、IGFBP-3≥0.74ng/L、CysC≥2.23ng/L、sVCAM-Ⅰ≥111.37ng/L、MMP9≥23.71ng/L、ASC mRNA≥22.55和NLRP3 mRNA≥21.98均是HSP患儿并发肾炎的危险因素(P<0.05)。限制性立方样条模型分析ASC mRNA和NLRP3 mRNA与HSP患儿并发肾炎的关系显示,ASC mRNA、NLRP3 mRNA均与HSP患儿并发肾炎存在非线性的剂量-反应关系。以HSP患儿并发肾炎的危险因素建立预测模型,并对其稳定性进行验证,模型具有良好的预测精准度。结论HSP患儿外周血单个核细胞中ASC mRNA、NLRP3 mRNA表达水平与患儿并发肾炎均存在关联。临床上应加强对ASC和NLRP3的监测,以减少HSP患儿并发肾炎的发生。 展开更多
关键词 过敏性紫癫 过敏性紫癜肾炎 凋亡相关斑点样蛋白 核苷酸结合寡聚化结构域样受体蛋白3 患儿
下载PDF
全身免疫炎症指数在儿童紫癜性肾炎中的预测价值
10
作者 裘艺莎 吴锴 +1 位作者 胡剑 孙兴珍 《安徽医药》 CAS 2024年第12期2497-2501,共5页
目的探讨全身免疫炎症指数(SII)对儿童紫癜性肾炎(HSPN)的预测价值。方法选取2019年6月至2022年12月于南京医科大学附属淮安第一医院住院治疗的161例过敏性紫癜病儿为研究对象,根据中华医学会儿科学分会肾脏病学组2016版HSPN诊治循证指... 目的探讨全身免疫炎症指数(SII)对儿童紫癜性肾炎(HSPN)的预测价值。方法选取2019年6月至2022年12月于南京医科大学附属淮安第一医院住院治疗的161例过敏性紫癜病儿为研究对象,根据中华医学会儿科学分会肾脏病学组2016版HSPN诊治循证指南中HSPN的诊断标准分为非肾炎组95例和肾炎组66例,应用多因素logistic回归分析HSPN的独立危险因素;Spearman相关性分析检验SII与HSPN病理分级严重程度的相关性;利用受试者操作特征曲线(ROC曲线)评估SII对HSPN的预测价值。结果肾炎组SII水平显著高于非肾炎组[792.30(472.58,1428.01)×10^(9)/L比501.41(311.97,962.26)×10^(9)/L,Z=−3.07,P=0.002],不同病理级别肾炎组间SII水平差异有统计学意义(Z=−3.21,P=0.001);SII[OR=1.002,95%CI:(1.000,1.004),P=0.038]是HSPN的独立危险因素;SII水平与HSPN病理分级严重程度呈正相关(r=0.54,P<0.001);SII预测HSPN的曲线下面积为0.64[95%CI:(0.56,0.73),P=0.002],最佳截断值为390.03×10^(9)/L,灵敏度和特异度分别为83.31%和43.20%。结论SII对预测HSPN及评估病理严重程度有一定的临床应用价值。 展开更多
关键词 过敏性紫癜性肾炎 全身免疫炎症指数 红细胞体积分布宽度 中性粒细胞计数/淋巴细胞计数比值 儿童
下载PDF
刘晓鹰教授治疗儿童紫癜性肾炎血尿蛋白尿型临床经验
11
作者 王天君 余亚玲 +1 位作者 刘晓鹰 刘加男 《世界中医药》 CAS 北大核心 2024年第11期1653-1659,共7页
目的:探讨刘晓鹰教授治疗儿童紫癜性肾炎(HSPN)血尿蛋白尿型的临床用药经验,为临床诊治HSPN提供思路。方法:对既往接诊的HSPN血尿蛋白尿型,仅用中药治疗且疗效为临床缓解和显效的病例,收集处方建立数据库,运用SPSS 23.0统计软件、R语言... 目的:探讨刘晓鹰教授治疗儿童紫癜性肾炎(HSPN)血尿蛋白尿型的临床用药经验,为临床诊治HSPN提供思路。方法:对既往接诊的HSPN血尿蛋白尿型,仅用中药治疗且疗效为临床缓解和显效的病例,收集处方建立数据库,运用SPSS 23.0统计软件、R语言、VOSviewer、Pajek软件分析药物频次、四气五味、归经以及药物规则。结果:纳入病例57例,处方955张,总药物309味,用药总频次15 584次。药物频次最高的前10位药物为甘草、茯苓、连翘、黄芪、赤芍、白术、紫草、漏芦、当归、茜草;药性以寒、凉为主,药味以甘、苦、辛为主,归经以肺、肝、胃、心、脾、肾为主;2味药物组合,提升度最高的为墨旱莲-女贞子;3味药物组合,提升度最高的为牡丹皮-紫草-赤芍;4味药物组合,提升度最高的为牡丹皮-地黄-赤芍-紫草。结论:在治疗HSPN时,抓住其“肺热、血瘀、脾虚”的主要病机特点,选用清肺热、清热凉血止血、活血化瘀、补中益气的中药对疾病进行分期辨证治疗。 展开更多
关键词 紫癜性肾炎 数据挖掘 用药规律 临床经验 中医药 儿童 @刘晓鹰
下载PDF
Mycophenolate mofetil plus prednisone for inducing remission of Henoch-Sch?nlein purpura nephritis: a retrospective study 被引量:8
12
作者 Fei HAN Liang-liang CHEN +5 位作者 Ping-ping REN Jing-yun LE Pei-jing CHOONG Hong-ju WANG Ying XU Jiang-hua CHEN 《Journal of Zhejiang University-Science B(Biomedicine & Biotechnology)》 SCIE CAS CSCD 2015年第9期772-780,共9页
Objective: The treatment of Henoch-Schonlein purpura (HSP) with moderate proteinuria remains con- troversial. We retrospectively analyzed the efficacy of immune suppressants, with a particular emphasis on myco- phe... Objective: The treatment of Henoch-Schonlein purpura (HSP) with moderate proteinuria remains con- troversial. We retrospectively analyzed the efficacy of immune suppressants, with a particular emphasis on myco- phenolate mofetil (MMF). Methods: Ninety-five HSP patients with moderate proteinuria (1.0-3.5 g/24 h) after at least three months of therapy with angiotensin-converting enzyme inhibitor (ACEI) or angiotensin receptor blocker (ARB) were divided into three groups: an MMF group (n=33) that received MMF 1.0-1.5 g/d combined with prednisone (0.4-0.5 mg/(kg.d)), a corticosteroid (CS) group (n=31) that received full-dose prednisone (0.8-1.0 mg/(kg.d)), and a control group (n=31). Patients in the MMF and CS groups continued to take ACEI or ARB at the original dose. The patients in the control group continued to take ACEI or ARB but the dose was increased by (1.73±0.58)-fold. The patients were followed up for 6-78 months (median 28 months). Results: The baseline proteinuria was higher in the MMF group ((2.1±0.9) g/24 h) than in the control group ((1.6±0.8) g/24 h) (P=0.039). The proteinuria decreased sig- nificantly in all groups during follow-up, but only in the MMF group did it decrease significantly after the first month. At the end of follow-up, the proteinuria was (0.4±0.7) g/24 h in the MMF group and (0.4±0.4) g/24 h in the CS group, significantly lower than that in the control group ((0.9±1.1) g/24 h). The remission rates in the MMF group, CS group, and control group were respectively 72.7%, 71.0%, and 48.4% at six months and 72.7%, 64.5%, and 45.2% at the end of follow-up. The overall number of reported adverse events was 17 in the MMF group, 30 in the CS group, and 6 in the control group (P〈0.001). Conclusions: MMF with low-dose prednisone may be as effective as full-dose prednisone and tend to have fewer adverse events. Therefore, it is probably superior to conservative treatments of adult HSP patients with moderate proteinuria. 展开更多
关键词 henoch-schonlein purpura nephritis Mycophenolate mofetil REMISSION
原文传递
中医外治法在儿童紫癜性肾炎的应用
13
作者 魏明杰 张霞 《光明中医》 2024年第19期4008-4011,共4页
紫癜性肾炎是儿科常见的继发性肾小球疾病,中医外治法作为紫癜性肾炎的中医特色治疗常见手段之一,在控制蛋白尿、血尿及保护肾功能、改善患儿体质等方面均具有独特优势。经查阅中医外治法治疗儿童紫癜性肾炎的相关文献,从灸法、刺络疗... 紫癜性肾炎是儿科常见的继发性肾小球疾病,中医外治法作为紫癜性肾炎的中医特色治疗常见手段之一,在控制蛋白尿、血尿及保护肾功能、改善患儿体质等方面均具有独特优势。经查阅中医外治法治疗儿童紫癜性肾炎的相关文献,从灸法、刺络疗法、针刺疗法、穴位贴敷4个方面进行综述,总结中医外治法应用于紫癜性肾炎治疗中的重要意义及广阔前景。 展开更多
关键词 血证 紫癜性肾炎 中医外治法 儿童 研究进展
下载PDF
来氟米特对激素耐药型儿童紫癜性肾炎的临床疗效及安全性
14
作者 秦可佳 杨玲霞 +1 位作者 崇华学 郝普来 《黑龙江医药科学》 2024年第5期26-28,共3页
目的:探讨来氟米特在治疗激素耐药型儿童紫癜性肾炎(HSPN)中的效果及其安全性。方法:选取齐齐哈尔市第一医院2018年8月至2022年12月儿科收治的激素耐药型HSPN患儿69例,通过随机数字表法进行分组,分为试验组与对照组。试验组患儿接受激... 目的:探讨来氟米特在治疗激素耐药型儿童紫癜性肾炎(HSPN)中的效果及其安全性。方法:选取齐齐哈尔市第一医院2018年8月至2022年12月儿科收治的激素耐药型HSPN患儿69例,通过随机数字表法进行分组,分为试验组与对照组。试验组患儿接受激素联合来氟米特的治疗方案,而对照组则采用激素联合环磷酰胺的治疗方案。在治疗后的第6个月,分别对两组患儿进行临床疗效及药物副作用的评估。结果:在治疗前,两组患儿的24 h尿蛋白定量均值相近,无统计学差异(P>0.05)。在治疗6个月后,试验组患儿的尿红细胞数显著减少,效果优于对照组(P<0.05),在安全性评估方面,试验组患儿在治疗的全过程中,其转氨酶、血白细胞以及血小板数量均保持在正常范围内。结论:来氟米特在治疗激素耐药型HSPN具有显著的治疗效果,并且有良好的安全性。 展开更多
关键词 来氟米特 激素耐药 儿童紫癜性肾炎 疗效评估 安全性研究
下载PDF
过敏性紫癜性肾炎患儿肾小管功能检测 被引量:14
15
作者 黄岩杰 陈文霞 +3 位作者 郑宏 丁樱 云鹰 刘霞 《郑州大学学报(医学版)》 CAS 北大核心 2005年第5期853-855,共3页
目的:探讨尿视黄醇结合蛋白(RBP)、尿胱蛋白酶抑制剂C(CysC)、尿N-乙酰-β-D-氨基葡萄糖苷酶(NAG)的测定在判断小儿过敏性紫癜性肾炎(APN)肾小管-间质损伤中的临床意义。方法:用ELISA方法和酶-底物直接显色法测定24例APN患儿(肾穿报告... 目的:探讨尿视黄醇结合蛋白(RBP)、尿胱蛋白酶抑制剂C(CysC)、尿N-乙酰-β-D-氨基葡萄糖苷酶(NAG)的测定在判断小儿过敏性紫癜性肾炎(APN)肾小管-间质损伤中的临床意义。方法:用ELISA方法和酶-底物直接显色法测定24例APN患儿(肾穿报告提示急性病变10例,急性+慢性病变10例,另4例未见肾小管间质病变)尿液中RBP、CysC、NAG的含量,分析3者的相关性以及与肾小管-病理损伤的关系。结果:急性病变患儿与急性+慢性病变患儿RBP、CysC、NAG含量差异无统计学意义。24例患者中尿RBP/Cr和CysC/Cr异常百分率分别为58.3%(14/24)、50.0%(12/24),且两者有相关性(r=0.877,P<0.0001)。尿NAG的异常百分率为75.0%(18/24),与前两者无关。RBP、CysC、NAG在不同肾小球病理分级中差异均有统计学意义。结论:尿RBP、CysC、NAG3者联合检测对早期诊断和全面监测肾小管-间质损伤具有重要的临床意义。 展开更多
关键词 紫癜性肾炎 儿童 视黄醇结合蛋白 尿胱蛋白酶抑制剂C 尿N-乙酰-Β-D-氨基葡萄糖苷酶
下载PDF
紫癜性肾炎复发患儿的临床、病理、预后及复发因素分析 被引量:15
16
作者 龚晶 甘卫华 +3 位作者 丁桂霞 陈荣华 黄文彦 姜新猷 《实用儿科临床杂志》 CAS CSCD 北大核心 2005年第11期1108-1110,共3页
目的探讨紫癜性肾炎(HSPN)的复发因素及与预后相关的临床和病理特征。方法随访HSPN38例患儿2~15年,对获得的完整临床及病理资料进行分析,分别按其临床、病理类型,预后分级标准进行分类比较。结果患儿预后与起病时的临床分型、病理类型... 目的探讨紫癜性肾炎(HSPN)的复发因素及与预后相关的临床和病理特征。方法随访HSPN38例患儿2~15年,对获得的完整临床及病理资料进行分析,分别按其临床、病理类型,预后分级标准进行分类比较。结果患儿预后与起病时的临床分型、病理类型、小管间质损伤程度及正规治疗疗程密切相关,与发病年龄无关;在导致复发的因素中,感染、尤其上呼吸道感染最常见。结论为改善儿童HSPN预后,除积极控制感染、减少复发次数外,尽早肾活检、制定正规治疗方案极其重要。 展开更多
关键词 肾炎 过敏性紫癜性 儿童 预后 复发
下载PDF
儿童过敏性紫癜性肾炎药物治疗的Meta分析 被引量:59
17
作者 赵丹 王君 +3 位作者 李惠芳 张燕舞 丁洁 于力 《中国循证儿科杂志》 CSCD 2007年第2期88-101,共14页
目的儿童过敏性紫癜性肾炎(HSPN)是儿科常见的继发性肾小球疾病,多发于欧洲及亚洲地区,目前尚无统一治疗方案。应用Meta分析方法评价儿童HSPN药物治疗的疗效,为临床治疗及开展相关研究提供参考和帮助。方法检索Medline、PubMed、EMBASE... 目的儿童过敏性紫癜性肾炎(HSPN)是儿科常见的继发性肾小球疾病,多发于欧洲及亚洲地区,目前尚无统一治疗方案。应用Meta分析方法评价儿童HSPN药物治疗的疗效,为临床治疗及开展相关研究提供参考和帮助。方法检索Medline、PubMed、EMBASE、CBM、中国期刊网等数据库、学术会议资料和学位论文等,全面收集有关儿童HSPN药物治疗的文献。制定文献纳入及排除标准,并通过查阅文献制定效应指标的评价标准。由2名研究者分别独立筛选文献,符合纳入标准的文献按Shekelle等建议的标准进行文献质量评估,对照性研究按Juni量表进行质量评价。应用Review Manager4.2软件进行Meta分析,计算治疗组与对照组的治愈率及有效率的危险率差(RD)及其95%CI,对不能进行Meta分析的文献进行描述性分析,客观评价各种药物治疗方案的疗效。结果共检索到HSPH相关中、外文文献1948篇,从中筛选出儿童HSPN药物治疗的相关文献64篇,其中多中心RCT研究(Ⅰa级)1篇,单中心RCT研究(Ⅰb级)6篇,单中心对照研究(Ⅱa级)10篇,无对照的临床病例观察(Ⅱb级)34篇,病例报道(Ⅲ级)13篇。在各种药物治疗方案中应用最多的是激素联合免疫抑制剂的治疗,共纳入163例患儿,其中对照组87例,治疗组76例,治疗前除对照组16例、治疗组14例患儿有轻微肾脏损伤(B级临床状态)外,其余均有肾病水平蛋白尿(C级临床状态)。治疗组采用激素联合免疫抑制剂治疗,对照组单用激素治疗,Meta分析结果显示治疗组较对照组治愈率及有效率均高(治愈率比较的RD=-0.39,95% CI:-0.53^-0.25,有效率比较的RD=-0.43,95% CI:-0.66^-0.20),差异有统计学意义。进一步对激素联合静脉冲击环磷酰胺(CTX)的疗效进行单独分析,共纳入106例患儿,其中对照组57例,治疗组49例,症状均较重,为肾病水平蛋白尿和(或)肾功能下降。治疗组应用激素联合静脉冲击CTX,对照组单用激素治疗,评价结果显示治疗组较对照组治愈率及有效率均高(治愈率比较的RD=-0.48,95% CI:-0.74~0.23;有效率比较的RD=-0.60,95% CI:-0.81^-0.40),差异有统计学意义;1项多中心RCT研究提示,支持治疗加CTX口服较单纯进行支持治疗对于改善儿童HSPN病情差异无统计学意义;此外,激素联合其他免疫抑制剂(硫唑嘌呤、环孢素、霉酚酸酯和长春新碱等)、免疫调节剂、抗凝剂及血浆置换等研究仅限于单个文献的对照研究或非随机非对照的临床病例观察,依据这些证据难以从EBM的角度进行评价,其疗效尚不能肯定。结论目前儿童HSPN药物治疗种类繁多,缺乏统一方案。本研究分析发现,激素联合免疫抑制剂对于症状较重的HSPN患儿(肾病水平蛋白尿伴或不伴有肾功能不全)的疗效优于单用激素治疗,其中激素联合静脉冲击CTX疗效显著;支持治疗加CTX口服较单纯进行支持治疗对于改善HSPN患儿病情差异无统计学意义;但确切疗效仍有待于临床开展大规模、多中心RCT研究来证实。其他药物的疗效尚不能获得EBM的证据支持。 展开更多
关键词 儿童 过敏性紫癜 肾炎 META分析 药物治疗
下载PDF
血管紧张素原基因多态性与儿童过敏性紫癜及紫癜性肾炎的关系 被引量:16
18
作者 吴春蕾 樊忠民 +3 位作者 夏正坤 高远赋 任献国 刘光陵 《临床儿科杂志》 CAS CSCD 北大核心 2009年第4期314-316,共3页
目的探讨血管紧张素原(AGT)基因多态性与儿童过敏性紫癜(HSP)及紫癜性肾炎(HSPN)的相关性。方法使用病例对照研究,经PCR和RFLP方法检测AGT基因型。结果AGT基因型构成比在患病组与对照组、HSPN组与对照组之间差异有统计学意义(χ2=17.92... 目的探讨血管紧张素原(AGT)基因多态性与儿童过敏性紫癜(HSP)及紫癜性肾炎(HSPN)的相关性。方法使用病例对照研究,经PCR和RFLP方法检测AGT基因型。结果AGT基因型构成比在患病组与对照组、HSPN组与对照组之间差异有统计学意义(χ2=17.92、17.08,P均<0.01),但在HSP和HSPN之间差异无统计学意义(χ2=1.78,P=0.41)。AGT-TT基因型在患病组和HSPN组均明显高于对照组(P<0.01)。结论用标记物对过敏性紫癜以及紫癜性肾炎易感性的追踪提示,AGT M235T基因型与中国儿童HSP、HSPN之间有关联。 展开更多
关键词 血管紧张素原 基因多态性 过敏性紫癜 紫癜性肾炎 儿童
下载PDF
儿童紫癜性肾炎的临床病理及预后 被引量:21
19
作者 王旭 栾江威 +1 位作者 杨杏鲜 朱润庆 《临床儿科杂志》 CAS CSCD 北大核心 2008年第4期309-311,共3页
目的探讨儿童紫癜性肾炎的临床、病理类型及其与预后的关系。方法回顾性分析1999年6月-2006年6月住院的79例紫癜肾炎患儿的临床病理类型及预后的关系,其中72例随访1~6年。结果临床表现为血尿和蛋白尿、单纯性血尿、肾病综合征者最多,... 目的探讨儿童紫癜性肾炎的临床、病理类型及其与预后的关系。方法回顾性分析1999年6月-2006年6月住院的79例紫癜肾炎患儿的临床病理类型及预后的关系,其中72例随访1~6年。结果临床表现为血尿和蛋白尿、单纯性血尿、肾病综合征者最多,急进性肾炎最少。肾脏病理表现为系膜增生、肾小球硬化、新月体形成,分级以Ⅱ、Ⅲ级最多,Ⅱ级占73.3%。临床痊愈占70.8%,少数预后不良。结论紫癜性肾炎病理改变以Ⅱ、Ⅲ级为主;其预后与临床表现、病理分级密切相关。 展开更多
关键词 紫癜性肾炎 儿童 临床 病理
下载PDF
火把花根片治疗儿童过敏性紫癜肾炎的临床研究 被引量:19
20
作者 周建华 黄爱霞 +2 位作者 刘铜林 唐锦辉 匡裕玖 《中国中西医结合杂志》 CAS CSCD 北大核心 2004年第5期418-421,共4页
目的 探讨火把花根片对儿童过敏性紫癜肾炎(Henoch-Schonlein purpura nephritis,HSPN)综合征型和肾病综合征型的治疗作用,并与雷公藤多甙片进行对比研究。方法 82例儿童HSPN,分为雷公藤多甙片和火把花根片治疗组,肾炎型单独应用雷公藤... 目的 探讨火把花根片对儿童过敏性紫癜肾炎(Henoch-Schonlein purpura nephritis,HSPN)综合征型和肾病综合征型的治疗作用,并与雷公藤多甙片进行对比研究。方法 82例儿童HSPN,分为雷公藤多甙片和火把花根片治疗组,肾炎型单独应用雷公藤多甙片或火把花根片治疗,肾病型分别联合泼尼松口服,6个月后观察两组疗效及尿蛋白、尿视黄醇结合蛋白(retinal-binding protein,RBP)、尿N-乙酰β-D氨基葡萄糖苷酶(N-acetyl-beta-glucosaminidase,NAG)等相关指标变化。结果 火把花根片组肾炎型完全缓解率58.8%,部分缓解率为41.2%,雷公藤多甙片组完全缓解率、部分缓解率和无效率分别为20.8%、66.7%和12.5%。两组结果比较,差异有显著性(P<0.05,P<0.01)。火把花根片组肾病型完全缓解率高于雷公藤多甙片组,但差异无显著性(P>0.05)。两组均能显著降低HSPN患儿尿蛋白、尿RBP和NAG水平,肾炎型火把花根片治疗组6个月时尿蛋白量低于雷公藤多甙片治疗组,差异有显著性(P<0.05)。结论 火把花根片对儿童HSPN肾炎型和肾病型及肾小管-间质的病变均有显著疗效,其对HSPN肾炎型降尿蛋白效果及总疗效好于雷公藤多甙片。 展开更多
关键词 火把花根片 儿童 过敏性紫癜肾炎 HSPN 雷公藤多甙片
下载PDF
上一页 1 2 14 下一页 到第
使用帮助 返回顶部